RESEARCH TRIANGLE PARK, CAROLINA DEL NORTE --(Business Wire)-- Quintiles es el líder en la industria que mejor se diferencia a sí mismo en prestación de servicios de calidad en las fases II/III de investigación clínica, según 157 profesionales ... TMC Net, 1 day ago
QUINTILES TRANSNATIONAL HOLDINGS INC: Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research - 4 Traders, 1 day ago
Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research - NewsBlaze, 1 day ago
See all (119) images for "quintiles"
StreetInsider.com - Form 10-Q Quintiles Transnational For:Street Insider, 1 week ago Form 424B4 Quintiles Transnational BusinessWeek, 1 week ago *Form CERTNYS Quintiles Transnational BusinessWeek, 2 weeks ago Form S-1/A Quintiles Transnational BusinessWeek, 3 weeks ago
StreetInsider.com - Form 4 Quintiles Transnational For: May 14 Filed by: GILLINGS DENNIS BStreet Insider, 1 week ago Form 3 Quintiles Transnational For: May 08 Filed by: Williams Charles Edward BusinessWeek, 2 weeks ago
|TheStreet.com, 1 week ago Emerge Energy (EMES) IPO Opens Lower Street Insider, 1 week ago|
Contract research organization Quintiles made its return to the market last week with a nearly $950 million IPO. The largest CRO was acquired by a private equity syndicate that included Bain Capital back in 2008. The private equity firms made a ...Motley Fool, 1 week ago Quintiles, PennyMac, Cyan Lead Large IPO Pack Investors Business Daily, 2 weeks ago
Of the new drugs approved from 2004 through 2011, Quintiles was involved with 85 percent of the central nervous system drugs, 76 percent of oncology drugs and 72 percent of cardiovascular drugs. Mad Money host Jim Cramer explains why the stock isCNBC, 1 week ago
Sign up for Healthcare Newsletter Print | Share | Reprint by Thomas Zadvydas and Taina Rosa | Published May 10, 2013 at 9:18 AM Private equity-backed Quintiles Transnational Holdings Inc. raised about $947.4 million when it priced its initial public ...TheDeal.com, 1 week ago Quintiles shares rise 10 pct in market debut Globe and Mail, 1 week ago Quintiles (Q) finshed its IPO debut today in the green, with the company's shares ending the day at $42.11, up more than 5% from their initial offering price of $40. The company provides testing and diagnostic services to biopharmaceutical companies, an Seeking Alpha, 1 week ago Quintiles shares rise 11 percent in market debut Mumbai News.Net, 1 week ago
Post a comment Print this blog postE-mail blog post Share Quintiles Chairman Dennis Gillings, center, and CEO Tom Pike, to Gilling's right, join other senior Quintiles executive to ring the "Opening Bell at the New York Stock Exchange on Friday.Local Tech Wire, 1 week ago Quintiles (Q) IPO Surges Higher Street Insider, 1 week ago Video: Quintiles Celebrates IPO on NYSE NBCNews.com, 1 week ago Quintiles Celebrates IPO on NYSE NBCNews.com, 1 week ago
NEW YORK (TheDeal) -- Quintiles Transnational Holdings (Q) Shares were little changed Friday at $42.07 after gaining 5.3% on Thursday, the company's debut on the New York Stock Exchange. The offering valued the Durham, N.C.-based provider of ...TheStreet.com, 1 week ago
Quintiles Transnational (Q) , the drug clinical trials giant, got a decent reception on the NYSE Thursday in a busy day for IPOs. The largest contract research organization's shareholders late Wednesday decided to offer 4 million shares more than ...Yahoo! Finance, 1 week ago
on your WebpageAdd Widget >Get your members hooked!